Skip to main content
. 2021 Aug 9;8(6):e1059. doi: 10.1212/NXI.0000000000001059

Figure 3. Proportion of Patients Experiencing Relapse-Associated Worsening (RAW) and Progression Independent From Relapse Activity (PIRA) by Disease Activity After 2 Years From Treatment Start (Median Follow-up Time of 12 Years).

Figure 3

EDA-3 = evidence of disease activity-3 (n = 463); NEDA-3 = no evidence of disease activity-3 (n = 224).